Stent-Assisted Angioplasty of Symptomatic Intracranial Vertebrobasilar Artery Stenosis: Feasibility and Follow-up Results

References

1. ↵
   Moufarrij NA, Little JR, Furlan AJ, Leatherman JR, Williams GW. Basilar and distal vertebral artery stenosis: long-term follow-up. Stroke 1986;17:938–942

   Abstract/FREE Full Text
2. Ausman JI, Shrontz CE, Pearce JE, Diaz FG, Crecelius JL. Vertebrobasilar insufficiency: a review. Arch Neurol 1985;42:803–808

   CrossRefPubMedWeb of Science
3. ↵
   The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 1998;29:1389–1392

   Abstract/FREE Full Text
4. ↵
   Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998;19:1525–1533

   Abstract
5. ↵
   Connors JJ 3rd, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999;91:415–423

   PubMedWeb of Science
6. ↵
   Marks MP, Do HM. Endovascular and Percutaneous Therapy of theBbrain and Spine. Philadelphia: Lippincott Williams & Wilkins,2002
7. ↵
   Sundt TM Jr, Smith HC, Campbell JK, Vlietstra RE, Cucchiara RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980;55:673–680

   PubMedWeb of Science
8. Higashida RT, Hieshima GB, Tsai FY, Halbach VV, Norman D, Newton TH. Transluminal angioplasty of the vertebral and basilar artery. AJNR Am J Neuroradiol 1987;8:745–749

   Abstract/FREE Full Text
9. Purdy PD, Devous MD Sr, Unwin DH, Giller CA, Batjer HH. Angioplasty of an atherosclerotic middle cerebral artery associated with improvement in regional cerebral blood flow. AJNR Am J Neuroradiol 1990;11:878–880

   FREE Full Text
10. ↵
    Mori T, Kazita K, Mori K. Cerebral angioplasty and stenting for intracranial vertebral atherosclerotic stenosis. AJNR Am J Neuroradiol 1999;20:787–789

    Abstract/FREE Full Text
11. Morris PP, Martin EM, Regan J, Braden G. Intracranial deployment of coronary stents for symptomatic atherosclerotic disease. AJNR Am J Neuroradiol 1999;20:1688–1694

    Abstract/FREE Full Text
12. ↵
    Horowitz MB, Pride GL, Graybeal DF, Purdy PD. Percutaneous transluminal angioplasty and stenting of midbasilar stenoses: three technical case reports and literature review. Neurosurgery 1999;45:925–930; discussion 930–921

    PubMedWeb of Science
13. Gomez CR, Misra VK, Campbell MS, Soto RD. Elective stenting of symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 2000;21:971–973

    Abstract/FREE Full Text
14. ↵
    Lanzino G, Fessler RD, Miletich RS, Guterman LR, Hopkins LN. Angioplasty and stenting of basilar artery stenosis: technical case report. Neurosurgery 1999;45:404–407; discussion 407–408

    PubMedWeb of Science
15. ↵
    Mori T, Kazita K, Chokyu K, Mima T, Mori K. Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 2000;21:249–254

    Abstract/FREE Full Text
16. ↵
    Gomez CR, Misra VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31:95–99

    Abstract/FREE Full Text
17. ↵
    Rasmussen PA, Perl J 2nd, Barr JD, et al. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience. J Neurosurg 2000;92:771–778

    PubMedWeb of Science
18. ↵
    Levy EI, Horowitz MB, Koebbe CJ, et al. Transluminal stent-assisted angiplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 2001;48:1215–1221; discussion 1221–1213

    CrossRefPubMedWeb of Science
19. ↵
    Levy EI, Hanel RA, Bendok BR, et al. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg 2002;97:1294–1301

    CrossRefPubMedWeb of Science
20. ↵
    Levy EI, Hanel RA, Boulos AS, et al. Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar artery. J Neurosurg 2003;99:653–660

    CrossRefPubMedWeb of Science
21. ↵
    Piotin M, Blanc R, Kothimbakam R, Martin D, Ross IB, Moret J Primary basilar artery stenting: immediate and long-term results in one patient. AJR Am J Roentgenol 2000;175:1367–1369

    PubMed
22. ↵
    SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke 2004;35:1388–1392

    Abstract/FREE Full Text
23. ↵
    Lincoff AM. Stent scrutiny. JAMA 2000;284:1839–1841

    CrossRefPubMed
24. ↵
    Coller BS. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest 1997;99:1467–1471

    CrossRefPubMedWeb of Science
25. ↵
    The EPIC Investigation. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956–961

    CrossRefPubMedWeb of Science
26. Reverter JC, Beguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody: potential implications for the effect of c7E3 Fab treatment on acute thrombosis and “clinical restenosis”. J Clin Invest 1996;98:863–874

    CrossRefPubMedWeb of Science
27. ↵
    Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 1999;99:2720–2732

    Abstract/FREE Full Text
28. ↵
    Kwon OK, Lee KJ, Han MH, Oh CW, Han DH, Koh YC. Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases. AJNR Am J Neuroradiol 2002;23:447–451

    Abstract/FREE Full Text
29. ↵
    Mounayer C, Piotin M, Baldi S, Spelle L, Moret J. Intraarterial administration of abciximab for thromboembolic events occurring during aneurysm coil placement. AJNR Am J Neuroradiol 2003;24:2039–2043

    Abstract/FREE Full Text
30. ↵
    Bhargava B, Karthikeyan G, Abizaid AS, Mehran R. New approaches to preventing restenosis. BMJ 2003;327:274–279

    FREE Full Text
31. ↵
    Holmes DR Jr. In-stent restenosis. Rev Cardiovasc Med 2001;2:115–119

    PubMed
32. ↵
    Haude M, Erbel R, Issa H, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 1993;126:15–22

    PubMedWeb of Science
33. ↵
    Mudra H, Klauss V, Blasini R, et al. Ultrasound guidance of Palmaz-Schatz intracoronary stenting with a combined intravascular ultrasound balloon catheter. Circulation 1994;90:1252–1261

    Abstract/FREE Full Text
34. ↵
    Moussa I, Di Mario C, Di Francesco L, Reimers B, Blengino S, Colombo A. Subacute stent thrombosis and the anticoagulation controversy: changes in drug therapy, operator technique, and the impact of intravascular ultrasound. Am J Cardiol 1996;78:13–17

    PubMedWeb of Science
35. ↵
    Holmes DR Jr, Hirshfeld J Jr, Faxon D, Vlietstra RE, Jacobs A, King SB 3rd. ACC expert consensus document on coronary artery stents: document of the American College of Cardiology. J Am Coll Cardiol 1998;32:1471–1482

    CrossRefPubMedWeb of Science
36. ↵
    Alfonso F, Goicolea J, Hernandez R, et al. Arterial perforation during optimization of coronary stents using high-pressure balloon inflations. Am J Cardiol 1996;78:1169–1172

    PubMed